Daniel L. Reuvers has been at the helm of Tactile Systems Technology, Inc. (TCMD) as the CEO since June 2020. With a master's degree from Harvard Business School, he brings deep expertise in the medical device industry. His leadership has...

Daniel L. Reuvers has been at the helm of Tactile Systems Technology, Inc. (TCMD) as the CEO since June 2020. With a master's degree from Harvard Business School, he brings deep expertise in the medical device industry. His leadership has seen the company navigate ups and downs, with total annual compensation reaching $2.2 million in 2022, showing how his performance aligns with company goals. Notably, he has been actively involved in the company’s strategic growth, including a significant acquisition during his time at Integra LifeSciences, where he served as Executive VP and led the Codman Specialty Surgical business. Interestingly, he plans to retire in June 2024, transitioning to an advisory role, which reflects a strategy to ensure continuity as he passes the baton to a new CEO. During his time, he's also shown a solid commitment to aligning his financial interests with shareholder performance, pointing to a 31:1 ratio of his compensation to the median employee. His insider trading history shows significant engagement with his company's stock, indicating that he believes in the value of the business and its potential growth.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Tactile Systems Technology CEOs

T

Daniel L. Reuvers

Ex-CEO of Tactile Systems Technology

Education

Master's degree in Business Administration from Harvard Business School.

Sector of Economy

Healthcare

Born

January 1, 1969 - 56 years ago

CEO of Tactile Systems Technology for

3 years 6 months (Dec 2020 - Jun 2024)

Previous Experience

CEO of Tactile Systems Technology, Inc.; held various executive roles in the medical device industry.

Rivals

Competitors/colleagues of Daniel L. Reuvers

Holdings

See how much did Daniel L. Reuvers make over time.

Daniel Reuvers has shown a strong commitment to Tactile Systems Technology, displaying an impressive history of stock holdings. In 2021, his stock holdings peaked at around $4.68 million, as he actively traded shares, showcasing confidence in the company’s performance. By...

Daniel Reuvers has shown a strong commitment to Tactile Systems Technology, displaying an impressive history of stock holdings. In 2021, his stock holdings peaked at around $4.68 million, as he actively traded shares, showcasing confidence in the company’s performance. By 2023, though fluctuations in value occurred, his holdings remained significant, dropping to approximately $3.76 million in February. The year saw him consistently holding substantial stakes, with values reaching as high as $4.93 million in July 2023. This trajectory indicates not just a tactical approach to stock management but also a belief in the company's long-term strategy, as he continues to navigate the complexities of the medical device sector.

Mar 18, 2025

I

shares

IART @ $22.62

T

shares

TCMD @ $13.66

Total Stock Sold

$2.94M

IART

$1.74M

34,266 IART shares

TCMD

$1.20M

71,048 TCMD shares

What if they kept their stock?

If Daniel L. Reuvers didn't sell their stock, today they would have:
Extra IART34,266 shares worth $1.90M and TCMD71,048 shares worth $3.36M.
This is 78.73% and $2.31M more than what they got when they sold the stock.

Charitable Transactions

IART

200 shares

IART

Recent Charitable Transactions

IART

200 shares

IART

Mar 13, 2020

Charity

Insider Trading

See recent insider trades of Daniel L. Reuvers.

TCMD

$401.85K

TCMD at $14.18/share

Feb 25, 2025

Sale

TCMD

$159.15K

TCMD at $14.55/share

Feb 20, 2025

Sale

TCMD

15,853 shares

TCMD

Feb 20, 2025

Received

TCMD

$93.86K

TCMD at $15.43/share

Feb 27, 2024

Sale

TCMD

$178.08K

TCMD at $15.33/share

Feb 23, 2024

Sale

TCMD

58,030 shares

TCMD

Feb 23, 2024

Received

TCMD

72,046 shares

TCMD

Feb 21, 2024

Received

TCMD

$21.81K

TCMD at $20.53/share

Aug 7, 2023

Sale

TCMD

$105.69K

TCMD at $14.91/share

Feb 25, 2023

Sale

TCMD

6,482 shares

TCMD

Feb 25, 2023

Received

Compensation History

See how much did Daniel L. Reuvers make over time.

In 2023, Daniel L. Reuvers’s total compensation amounted to approximately $1.36 million, with a base salary of $650,000, a substantial bonus of $708,500 linked to revenue and EBITDA targets, and some additional benefits. This marked a significant decrease from 2022, when his compensation peaked at $2.2 million, largely due to a higher bonus associated with superior financial performance. His approach to compensation reflects a keen awareness of aligning executive pay with company success, as he did not receive stock vesting or option grants in 2023. Reuvers’ structured compensation plan is designed not only to attract and retain talent but also to ensure that executive rewards are tied to real performance, a critical measure in the competitive field of medical devices.

Year

2023

Total Compensation

$1.36M

Salary

$650.00K

Board Justification

The compensation philosophy is designed to attract and retain talented individuals while aligning executive compensation with company performance and shareholder interests.

Bonus

$708.50K

Board Justification

The bonus is based on the Management Incentive Plan (MIP) which ties compensation to the achievement of revenue and Adjusted EBITDA goals for the year 2023.

Other

$6.10K

Board Justification

Other compensation includes contributions to the 401(k) plan.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock was reported as vested in 2023 for the purpose of this compensation summary.

Performance Metrics

Performance metrics for the bonus include revenue and Adjusted EBITDA goals.

Other Tactile Systems Technology CEOs

Here are other CEOs of Tactile Systems Technology

Gerald R. Mattys

Ex-CEO of Tactile Systems Technology

November 2013 - December 2020

Sheri L. Dodd

CEO of Tactile Systems Technology

July 2024 - Present